These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 12690618

  • 1. Opioid equianalgesic conversion: the right dose.
    Brant JM.
    Clin J Oncol Nurs; 2001; 5(4):163-5. PubMed ID: 12690618
    [Abstract] [Full Text] [Related]

  • 2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [Abstract] [Full Text] [Related]

  • 3. Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain.
    Weinstein SM, Shi M, Buckley BJ, Kwarcinski MA.
    Clin Ther; 2006 Jan; 28(1):86-98. PubMed ID: 16490582
    [Abstract] [Full Text] [Related]

  • 4. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S, Porzio G, Ferrera P, Fulfaro F, Aielli F, Verna L, Villari P, Ficorella C, Gebbia V, Riina S, Casuccio A, Mangione S.
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [Abstract] [Full Text] [Related]

  • 5. Clinical experience with transdermal and orally administered opioids in palliative care patients--a retrospective study.
    Clemens KE, Klaschik E.
    Jpn J Clin Oncol; 2007 Apr; 37(4):302-9. PubMed ID: 17519302
    [Abstract] [Full Text] [Related]

  • 6. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
    Benítez-Rosario MA, Feria M, Salinas-Martín A, Martínez-Castillo LP, Martín-Ortega JJ.
    Cancer; 2004 Dec 15; 101(12):2866-73. PubMed ID: 15529307
    [Abstract] [Full Text] [Related]

  • 7. Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: comparison of extended-release oxycodone and OROS hydromorphone.
    Ward A, Bozkaya D, Fleischmann J, Dubois D, Sabatowski R, Caro JJ.
    Curr Med Res Opin; 2007 Oct 15; 23(10):2333-45. PubMed ID: 17697453
    [Abstract] [Full Text] [Related]

  • 8. Inconsistencies in opioid equianalgesic ratios: clinical and research implications.
    O'Bryant CL, Linnebur SA, Yamashita TE, Kutner JS.
    J Pain Palliat Care Pharmacother; 2008 Oct 15; 22(4):282-90. PubMed ID: 21923312
    [Abstract] [Full Text] [Related]

  • 9. Outcomes after intravenous opioids in emergency patients: a prospective cohort analysis.
    O'Connor AB, Zwemer FL, Hays DP, Feng C.
    Acad Emerg Med; 2009 Jun 15; 16(6):477-87. PubMed ID: 19426295
    [Abstract] [Full Text] [Related]

  • 10. Oral versus intravenous opioid dosing for the initial treatment of acute musculoskeletal pain in the emergency department.
    Miner JR, Moore J, Gray RO, Skinner L, Biros MH.
    Acad Emerg Med; 2008 Dec 15; 15(12):1234-40. PubMed ID: 18945240
    [Abstract] [Full Text] [Related]

  • 11. Opioid switch in palliative care, opioid choice by clinical need and opioid availability.
    Müller-Busch HC, Lindena G, Tietze K, Woskanjan S.
    Eur J Pain; 2005 Oct 15; 9(5):571-9. PubMed ID: 16139186
    [Abstract] [Full Text] [Related]

  • 12. [Treatment of pain in cancer with systemically administered opioids].
    Enting RH, van der Rijt CC, Wilms EB, Lieverse PJ, de Wit R, Smitt PA.
    Ned Tijdschr Geneeskd; 2001 May 19; 145(20):950-4. PubMed ID: 11396259
    [Abstract] [Full Text] [Related]

  • 13. Opioid equianalgesic tables: are they all equally dangerous?
    Shaheen PE, Walsh D, Lasheen W, Davis MP, Lagman RL.
    J Pain Symptom Manage; 2009 Sep 19; 38(3):409-17. PubMed ID: 19735901
    [Abstract] [Full Text] [Related]

  • 14. Safety and effectiveness of intravenous morphine for episodic (breakthrough) pain using a fixed ratio with the oral daily morphine dose.
    Mercadante S, Villari P, Ferrera P, Bianchi M, Casuccio A.
    J Pain Symptom Manage; 2004 Apr 19; 27(4):352-9. PubMed ID: 15050663
    [Abstract] [Full Text] [Related]

  • 15. Opioid rotation from morphine to fentanyl in delirious cancer patients: an open-label trial.
    Morita T, Takigawa C, Onishi H, Tajima T, Tani K, Matsubara T, Miyoshi I, Ikenaga M, Akechi T, Uchitomi Y, Japan Pain, Rehabilitation, Palliative Medicine, and Psycho-Oncology (PRPP) Study Group.
    J Pain Symptom Manage; 2005 Jul 19; 30(1):96-103. PubMed ID: 16043013
    [Abstract] [Full Text] [Related]

  • 16. Morphine and alternative opioids in cancer pain: the EAPC recommendations.
    Hanks GW, Conno F, Cherny N, Hanna M, Kalso E, McQuay HJ, Mercadante S, Meynadier J, Poulain P, Ripamonti C, Radbruch L, Casas JR, Sawe J, Twycross RG, Ventafridda V, Expert Working Group of the Research Network of the European Association for Palliative Care.
    Br J Cancer; 2001 Mar 02; 84(5):587-93. PubMed ID: 11237376
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain.
    van Seventer R, Smit JM, Schipper RM, Wicks MA, Zuurmond WW.
    Curr Med Res Opin; 2003 Mar 02; 19(6):457-69. PubMed ID: 14594516
    [Abstract] [Full Text] [Related]

  • 19. [New option in the management of cancer pain in Hungary: short acting oral opioid therapy].
    Kullmann T, Sipőcz I, Csikós Á, Pintér T.
    Orv Hetil; 2015 Jun 21; 156(25):1003-6. PubMed ID: 26170088
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.